BUSINESS

• Lilly to Withdraw Taltz from Wholesaler Inventory; Distributor Execs Irked by MHLW’s Price Handling
  August 31, 2016

• Santen, Kerui Set Up Ophthalmic JV in China
  August 31, 2016

• Oropharyngeal Candidiasis Drug Hits Primary Endpoint in PIII: Sosei
  August 30, 2016

• Seikagaku, Ferring Finalize Licensing Deal for Lumbar Disc Herniation Drug
  August 30, 2016

• Nichi-Iko Completes Tender Offer for Sagent
  August 30, 2016

• Shionogi’s Sakigake-Designated Flu Med Shows Efficacy in Japan PII
  August 30, 2016

• Hisamitsu’s NSAIDs Patch Disappoints in Japan PII/III
  August 30, 2016

• Mylan, Pfizer Recalling 2 Generic Products in Japan
  August 29, 2016

• Vimpat Filed for Monotherapy Approval in Japan: Daiichi Sankyo, UCB
  August 29, 2016

• Sizzling DOAC Market - 4: Companies Aim to Differentiate Their Products through Quality of Information
  August 29, 2016

• CSL Behring Seeks Approval of Human Prothrombin Complex
  August 26, 2016

• Actemra Filed for Weekly Dosage for Inadequately Controlled RA
  August 26, 2016

• Mitsubishi Tanabe Transitions from “Open Innovation” to “Open Shared” System: President
  August 26, 2016

• Sizzling DOAC Market - 3: Dosage and Administration Vary by Product for PE/DVT Treatment
  August 26, 2016

• Sizzling DOAC Market - 2: Makers Accumulating Data from Actual Clinical Settings to Support Proper Use
  August 25, 2016

• Announcement: Real World Data Japan 2016 to Be Held at Westin Tokyo Hotel on October 18-19
  August 25, 2016

• Sizzling DOAC Market - 1: Japan Sales Reaching 140 Billion Yen on 4-Way Fight
  August 24, 2016

• Canaglu-Tenelia Combo Filed in Japan: Mitsubishi Tanabe
  August 23, 2016

• GSK Paid 6.2 Billion Yen to Doctors, Medical Institutions in 2015
  August 23, 2016

• New Treatment Options Arriving in Multiple Myeloma Arena
  August 23, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 460
• 461
• 462
• 463
• 464
• 465
• 466
• 467
• 468
• …
• Next ›
• 最終 »